Literature DB >> 8853040

Bronchoalveolar lavage cytology in pulmonary alveolar proteinosis.

A Burkhalter1, J F Silverman, M B Hopkins, K R Geisinger.   

Abstract

Pulmonary alveolar proteinosis (PAP) is an uncommon disease in which alveoli are progressively filled with surfactant-related material. Although a definitive diagnosis is usually made by an open lung biopsy, bronchoalveolar lavage (BAL) cytology may play a decisive role in the clinical work-up of these patients, and, in some cases, may spare a patient a more invasive diagnostic procedure. The authors present three patients in whom BAL cytology specimens contained the characteristic (although not specific) globules of amorphous proteinaceous PAS-positive material accompanied by only rare background macrophages and inflammatory cells. The patients include a 40-year-old man with an 8-year history of fever of unknown origin, a 30-year-old man with a chronic nonproductive cough, and a 6-year-old boy diagnosed at 5 months of age with osteopetrosis and hypogammaglobulinemia who subsequently developed a disseminated Mycobacterium avium-intracellulare infection. All specimens stained with Gomori methenamine silver (3) and Ziehl-Neelsen (2) were negative for microbial organisms, Ultrastructural examination of two specimens revealed the characteristic lamellar structures of surfactant, increasing diagnostic specificity. Lung biopsies and/or autopsy subsequently confirmed the diagnosis in all three cases. The characteristic cytologic and ultrastructural features of PAP in BAL specimens are presented along with the morphologic differential features of other entities which potentially could be confused with PAP.

Entities:  

Mesh:

Year:  1996        PMID: 8853040     DOI: 10.1093/ajcp/106.4.504

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Pulmonary involvement of peripheral T-cell lymphoma manifesting as crazy paving pattern.

Authors:  Traci Fraser; Amulya Nagarur
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-01

Review 3.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

4.  Pulmonary alveolar proteinosis: diagnosis using routinely processed smears of bronchoalveolar lavage fluid.

Authors:  T Mikami; Y Yamamoto; M Yokoyama; I Okayasu
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

5.  Primary pulmonary alveolar proteinosis: computed tomography features at diagnosis.

Authors:  Laureline Berteloot; Rola Abou Taam; Sophie Emond-Gonsard; Tania Mamou-Mani; Karen Lambot; David Grévent; Caroline Elie; Muriel Le Bourgeois; Christophe Delacourt; Francis Brunelle; Jacques de Blic
Journal:  Pediatr Radiol       Date:  2014-03-06

6.  Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report.

Authors:  Hanne Beeckmans; Gene P L Ambrocio; Saskia Bos; Astrid Vermaut; Vincent Geudens; Arno Vanstapel; Bart M Vanaudenaerde; Frans De Baets; Thomas L A Malfait; Marie-Paule Emonds; Dirk E Van Raemdonck; Hélène M Schoemans; Robin Vos
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

7.  Reply to McCarthy et al.: Lipid-Laden Macrophages Are Not Diagnostic of Pulmonary Alveolar Proteinosis Syndrome and Can Indicate Lung Injury.

Authors:  Anna-Karoline Israel; Matthew D McGraw; Tanupriya Agrawal
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.